Repetitive probing identifies nasolacrimal duct obstructions

Article

Repetitive probing with intranasal endoscopic imaging provides information about congenital nasolacrimal duct obstructions.

Repetitive probing with intranasal endoscopic imaging provides information about congenital nasolacrimal duct obstructions, claims a paper in the European Journal of Ophthalmology.

Dr S. Okumus et al., Department of Ophthalmology, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey, included 84 eyes of 64 patients who experienced unsuccessful primary probing. Each patient was divided into three groups according to the number of unsuccessful probing attempts. Group one included 50 eyes who experienced one unsuccessful probing, group two consisted of 23 eyes with two unsuccessful probings and group three had 11 eyes that underwent three.

History taking, clinical examination and fluorescence disappearance test confirmed the diagnosis of congenital nasolacrimal duct obstruction. Nasal endoscopic-assisted probing was performed in all eyes. All patients were followed-up on the first week, first month and third month, postoperatively.

The reasons for failure, as determined by endoscopy, were functional insufficiency in 8.3% of patients, lower nasal concha tension in 4.7%, thin membrane in Hasner valve in 3.6%, thick membrane and fibrosis in the distal side of the duct in 21.4%, probe progressed submucosally on the nasal wall in 33.3%, different exit location in the nose in 20.2%, nasal mucosa ballooning in the distal side of the duct in 4.7%, mucocele in 2.4% and nasal polyposis in 1.2%.

The predicted success rates for groups one, two and three were 86%, 69.5% and 54.5%, respectively. Repetitive probings via nasal endoscopy was able to provide information on the location and shape of the obstruction.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.